Cited by 60Hematopoietic Stem Cell TransplantationAcute Myeloid Leukemia ResearchCancer Genomics and Diagnostics

Clonal dynamics after allogeneic haematopoietic cell transplantation

Open access
Spencer Chapman, Michael, Wilk, C. Matthias, Boettcher, Steffen, Mitchell, Emily, Dawson, Kevin, Williams, Nicholas, Müller, Jan, Kovtonyuk, Larisa +9 more·2024·Nature

Published version of a preprint

Abstract

Allogeneic haematopoietic cell transplantation (HCT) replaces the stem cells responsible for blood production with those from a donor 1,2 . Here, to quantify dynamics of long-term stem cell engraftment, we sequenced genomes from 2,824 single-cell-derived haematopoietic colonies of ten donor–recipient pairs taken 9–31 years after HLA-matched sibling HCT 3 . With younger donors (18–47 years at transplant), 5,000–30,000 stem cells had engrafted and were still contributing to haematopoiesis at the time of sampling; estimates were tenfold lower with older donors (50–66 years). Engrafted cells made multilineage contributions to myeloid, B lymphoid and T lymphoid populations, although individual clones often showed biases towards one or other mature cell type. Recipients had lower clonal diversity than matched donors, equivalent to around 10–15 years of additional ageing, arising from up to 25-fold greater expansion of stem cell clones. A transplant-related population bottleneck could not explain these differences; instead, phylogenetic trees evinced two distinct modes of HCT-specific selection. In pruning selection, cell divisions underpinning recipient-enriched clonal expansions had occurred in the donor, preceding transplant—their selective advantage derived from preferential mobilization, collection, survival ex vivo or initial homing. In growth selection, cell divisions underpinning clonal expansion occurred in the recipient’s marrow after engraftment, most pronounced in clones with multiple driver mutations. Uprooting stem cells from their native environment and transplanting them to foreign soil exaggerates selective pressures, distorting and accelerating the loss of clonal diversity compared to the unperturbed haematopoiesis of donors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-024-08128-y

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Environmental factors and exposure to certain substances can significantly alter clonal composition, promoting positive selection and accelerating the physiological restriction of the stem cell pool.

    “While aging plays a critical role in driving these changes, it is well established that environmental factors and exposure to certain substances can significantly alter clonal composition promoting positive selection and accelerating the physiological restriction of the stem cell pool. 25-27”

    From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [27]

    The ‘Loss of clonal diversity after HCT’ section (page unavailable) reports that transplant recipients had lower clonal diversity than matched donors, equivalent on average to 12 additional years of ageing. The paper links this to transplant-specific selection and a changed marrow environment, but does not establish that environmental factors or exposure to substances generally accelerate restriction of the stem-cell pool. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Aging plays a critical role in driving changes in clonal composition.

    “While aging plays a critical role in driving these changes, it is well established that environmental factors and exposure to certain substances can significantly alter clonal composition promoting positive selection and accelerating the physiological restriction of the stem cell pool. 25-27”

    From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [27]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. [1]Sevilla, J., Fernández-Plaza, S., Diaz, M. A. & Madero, L. Hematopoietic transplantation for bone marrow failure syndromes and thalassemia. Bone Marrow Transplant 35, S17–S21 (2005). 15812523 · DOI
  2. [2]Dickinson, A. M. et al. Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia. Front. Immunol. 8, 496 (2017). 28638379 PMC5461268 · DOI
  3. [3]Boettcher, S. et al. Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation. Blood 135, 1548–1559 (2020). 32181816 · DOI
  4. [4]Atsuta, Y. et al. Late mortality and causes of death among long-term survivors after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant 22, 1702–1709 (2016). 27246369 · DOI
  5. [5]Wingard, J. R. et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J. Clin. Oncol. 29, 2230–2239 (2011). 21464398 PMC3107742 · DOI
  6. [6]Kollman, C. et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood 127, 260–267 (2016). 26527675 PMC4713163 · DOI
  7. [7]Kollman, C. et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98, 2043–2051 (2001). 11567988 · DOI
  8. [8]Lemischka, I. R., Raulet, D. H. & Mulligan, R. C. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45, 917–927 (1986). 2871944 · DOI
  9. [9]Rong, L., Neff, N., Quake, S. & Weissman, I. Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding. Nat. Biotechnol. 29, 928–933 (2012). PMC3196379 21964413
  10. [11]Sun, J. et al. Clonal dynamics of native haematopoiesis. Nature 514, 322–327 (2014). 25296256 PMC4408613 · DOI
  11. [13]Pei, W. et al. Polylox barcoding reveals haematopoietic stem cell fates realized in vivo. Nature 548, 456–460 (2017). 28813413 PMC5905670 · DOI
  12. [14]Bowling, S. et al. An engineered CRISPR-Cas9 mouse line for simultaneous readout of lineage histories and gene expression profiles in single cells. Cell 181, 1410–1422 (2020). 32413320 PMC7529102 · DOI
  13. [15]Biasco, L. et al. In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases. Cell Stem Cell 19, 107–119 (2015). PMC4942697 27237736 · DOI · Paper page
  14. [16]Scala, S. et al. Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans. Nat. Med. 24, 1683–1690 (2018). 30275570 · DOI
  15. [17]Osorio, F. G. et al. Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis. Cell Rep. 25, 2308–2316 (2018). 30485801 PMC6289083 · DOI
  16. [18]Spencer Chapman, M. et al. Lineage tracing of human development through somatic mutations. Nature 595, 85–90 (2021). 33981037 · DOI
  17. [19]Mitchell, E. et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature 606, 343–350 (2022). 35650442 PMC9177428 · DOI
  18. [20]Lee-Six, H. et al. Population dynamics of normal human blood inferred from somatic mutations. Nature 561, 473–478 (2018). 30185910 PMC6163040 · DOI · Paper page
  19. [21]Fabre, M. A. et al. The longitudinal dynamics and natural history of clonal haematopoiesis. Nature 606, 335–342 (2022). 35650444 PMC9177423 · DOI · Paper page
  20. [23]Pich, O. et al. The evolution of hematopoietic cells under cancer therapy. Nat. Commun. 12, 4803 (2021). 34376657 PMC8355079 · DOI
  21. [24]de Kanter, J. K. et al. Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients. Cell Stem Cell 28, 1726–1739 (2021). 34496298 PMC8516432 · DOI
  22. [25]Zou, X. et al. Short inverted repeats contribute to localized mutability in human somatic cells. Nucleic Acids Res. 45, 11213–11221 (2017). 28977645 PMC5737083 · DOI
  23. [26]Baker, S. C. et al. Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer. Oncogene 41, 2139–2151 (2022). 35194151 PMC8862006 · DOI
  24. [28]Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477–2487 (2014). 25426838 PMC4290021 · DOI · Paper page
  25. [29]Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472–1478 (2014). 25326804 PMC4313872 · DOI · Paper page
  26. [30]Gozdecka, M. et al. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. Nat. Genet. 50, 883–894 (2018). 29736013 PMC6029661 · DOI
  27. [31]Six, E. et al. Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programs. Blood 135, 1219–1231 (2020). 32040546 PMC7146019 · DOI
  28. [32]Macallan, D. C., Busch, R. & Asquith, B. Current estimates of T cell kinetics in humans. Curr. Opin. Syst. Biol. 18, 77–86 (2019). 31922055 PMC6941842 · DOI
  29. [34]Crotty, S. et al. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171, 4969–4973 (2003). 14607890 · DOI · Paper page
  30. [35]Gotuzzo, E., Yactayo, S. & Córdova, E. Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. Am. J. Trop. Med. Hyg. 89, 434–444 (2013). 24006295 PMC3771278 · DOI
  31. [36]Soerens, A. G. et al. Functional T cells are capable of supernumerary cell division and longevity. Nature 614, 762–766 (2023). 36653453 PMC11617068 · DOI
  32. [37]Oran, B. et al. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation. Leukemia 36, 257–262 (2022). 34135465 · DOI
  33. [38]Gibson, C. J. et al. Donor clonal hematopoiesis and recipient outcomes after transplantation. J. Clin. Oncol. 40, 189–201 (2022). 34793200 PMC8718176 · DOI · Paper page
  34. [40]Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041 (2017). 29056346 PMC5720395 · DOI · Paper page
  35. [41]Fritsch, K. et al. Engineered humanized bone organs maintain human hematopoiesis in vivo. Exp. Hematol. 61, 45–51 (2018). 29410245 · DOI
  36. [42]Ellis, P. et al. Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing. Nat. Protoc.10.1038/s41596-020-00437-6 (2020). 33318691 · DOI
  37. [43]Jones, D. et al. cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data. Curr. Protoc. Bioinform.2016, 15.10.1–15.10.18 (2016). PMC6097605 27930805
  38. [44]Ye, K., Schulz, M. H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865–2871 (2009). 19561018 PMC2781750 · DOI
  39. [45]Raine, K. M. et al. ascatNgs: identifying somatically acquired copy-number alterations from whole-genome sequencing data. Curr. Protoc. Bioinform.2016, 15.9.1–15.9.17 (2016). PMC6097604 27930809
  40. [46]Cameron, D. L. et al. GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. Genome Res.10.1101/gr.222109.117 (2017). PMC5741059 29097403 · DOI
  41. [47]Menzies, A. et al. VAGrENT: variation annotation generator. Curr. Protoc. Bioinform.52, 15.8.1–15.8.11 (2015). PMC6101192 26678383
  42. [48]Thi Hoang, D. et al. MPBoot: fast phylogenetic maximum parsimony tree inference and bootstrap approximation. BMC Ecol. Evol. 18, 11 (2018). PMC5796505 29390973
  43. [49]Yang, Z. & Rannala, B. Molecular phylogenetics: principles and practice. Nat. Rev. Genet.13, 303–314 (2012). 22456349
  44. [51]Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112–121 (2020). 32025012 PMC7025897 · DOI · Paper page
  45. [52]Gerstung, M., Papaemmanuil, E. & Campbell, P. J. Subclonal variant calling with multiple samples and prior knowledge. Bioinformatics 30, 1198–1204 (2014). 24443148 PMC3998123 · DOI
  46. [53]Zink, F. et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 130, 742–752 (2017). 28483762 PMC5553576 · DOI · Paper page
  47. [54]Bolton, K. L. et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat. Genet. 52, 1219–1226 (2020). 33106634 PMC7891089 · DOI · Paper page
  48. [55]Webb, C. O., Ackerly, D. D., McPeek, M. A. & Donoghue, M. J. Phylogenies and community ecology. Annu. Rev. Ecol. Syst. 33, 475–505 (2002). · DOI

Cited by

Sorted by citations

Authors
Spencer Chapman, M., Wilk, C. M., Boettcher, S., Mitchell, E., Dawson, K., Williams, N., Müller, J., Kovtonyuk, L., Jung, H., Caiado, F., Roberts, K., O’Neill, L., Kent, D. G., Green, A. R., Nangalia, J., Manz, M. G., & Campbell, P. J.
Affiliations
  • University of Zurich (CH)
  • Wellcome/MRC Cambridge Stem Cell Institute (GB)
  • Wellcome Sanger Institute (GB)
Corresponding author
  • Manz, Markus G.
  • Campbell, Peter J.
Venue
Nature
Published
2024-10-30
Volume
635
Issue
8040
Pages
926-934
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4403921094
Cited by
60
References
8
Citations by year
2026: 21 · 2025: 25 · 2024: 12 · 2023: 2
FWCI
17.93
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Wellcome Trust
  • Cancer Research UK (DCRPGF∖100008)
  • National Institute for Health and Care Research (CL-2023-19-005)
  • Blood Cancer UK (15008)
  • Medical Research Council (MC_PC_17230)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
allogeneic haematopoietic cell transplantation, clonal dynamics, hematopoietic stem cells, long-term engraftment, clonal diversity, clonal expansion, donor age, matched sibling donor, phylogenetic analysis, driver mutations, multilineage differentiation, hematopoiesis
MeSH terms
Adolescent, Adult, Aged, Cell Movement, Cell Survival, Clone Cells, Hematopoiesis, Hematopoietic Stem Cells, Humans, Male, Middle Aged, Mutation, Phylogeny, Selection, Genetic, Time Factors, Tissue Donors, Transplantation, Homologous, Cellular Senescence, Hematopoietic Stem Cell Transplantation, Cell Lineage, Siblings, Cell Proliferation, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review